Position in GILD
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$223,495
-$7,022 QoQ
Shares Held
1,769
+7.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,856
of 2,266 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fortitude Advisory Group L.L.C. holds $5,117,589 across 7 Drug Manufacturers - General names. GILD ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,327 | $1,591,643 | |
| 2 | ABBV |
AbbVie Inc.
|
5,707 | $1,436,109 | |
| 3 | JNJ |
Johnson & Johnson
|
3,255 | $826,672 | |
| 4 | AMGN |
Amgen Inc
|
1,258 | $455,546 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,728 | $350,548 | |
| 6 | PFE |
Pfizer Inc
|
9,700 | $233,576 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
1,769 | $223,495 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $223,495 | 1,769 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $230,517 | 1,654 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $265,609 | 2,164 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $236,541 | 2,131 | Shares | Sole | 2025-11-05 | |
| 2022-03-31 | $136,972 | 2,304 | Shares | Sole | 2022-05-25 | |
| 2021-12-31 | $46,470 | 640 | Shares | Sole | 2022-05-20 | |
| No filing history on record for this holder in this stock. | ||||||